<--- Back to Details
First PageDocument Content
Stethoscope / Amgen / Gilead Sciences / Sanofi / AstraZeneca / Business / Technology / Daiichi Sankyo / Pharmaceutical industry
Date: 2014-10-03 10:27:58
Stethoscope
Amgen
Gilead Sciences
Sanofi
AstraZeneca
Business
Technology
Daiichi Sankyo
Pharmaceutical industry

Add to Reading List

Source URL: www.exhibitatsessions.org

Download Document from Source Website

File Size: 277,05 KB

Share Document on Facebook

Similar Documents

Business / Pharmaceutical sciences / Biotechnology / Pharmacy / Pharmaceutical industry / Bristol-Myers Squibb / Daiichi Sankyo / Eli Lilly and Company / Biopharmaceutical / GlaxoSmithKline

April 1, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. Sponsored By:

DocID: 1rsbj - View Document

Chemistry / Organic chemistry / Angiotensin II receptor antagonists / Tetrazoles / Alcohols / Imidazoles / RTT / Losartan / Olmesartan / Valsartan / Sildenafil / Propranolol

benicar with hct what kind of med is benicar, benicar hc. benicar hct and insomnia. benicar hct tablets substitute benicar for micardis benicar contra drug side effect benicar benicar hct by daiichi-sankyo, benicar and b

DocID: 1r6JO - View Document

Pharmaceuticals policy / CNX Nifty / Serono / Ranbaxy Laboratories / Merck Group / Daiichi Sankyo / AstraZeneca / Pharmaceutical industry in China / Allergan /  Plc / Pharmaceutical industry / Biogen / Sigma-Aldrich

May 6, IMS Health, Quintiles Agree to Merge IMS Health Holdings, Inc., the pharmaceutical market information and technology provider, and Quintiles Transnational Holdings Inc., a contract rese

DocID: 1p3Zj - View Document

Press Release Daiichi Sankyo Provides Update on HER3-Lung Study of Patritumab in Non-Small Cell Lung Cancer (NSCLC) Tokyo, Japan and Parsippany, NJ– (May 31, 2016) – Daiichi Sankyo Company, Limited (hereafter, Daiich

DocID: 1o6nw - View Document

For Immediate Release ASAHIKAWA MEDICAL UNIVERSITY DAIICHI SANKYO COMPANY, LIMITED MITSUBISHI UFJ CAPITAL CO., LTD. Open innovation research on new stem cells by Asahikawa Medical University,

DocID: 1o1QP - View Document